Pembrolizumab for non-muscle-invasive bladder cancer – is it worth the cost? @arkhaki @SWilliams_MD
authors.elsevier.com/c/1eXVp14kplrE…
authors.elsevier.com/c/1eXVp14kplrE…
Divya A Parikh
@DivyaParikhMD
Oncologist with an interest in Health Services Research and GU Oncology
139 Following 137 Followers 19 Posts
Latest posts 5
Such an honor to present at #ASCO quality alongside my brilliant mentor @manalipatelmd! So grateful for opportunity to present our work and the thoughtful discussion by @MBakitas.
Our study of #financialtoxicity in disparate #cancercare systems was published in @ASCO_pubs #JCOOP! Thanks to the collaborative team @VAPaloAlto @StanfordCancer and SCVMC @meera_ragavan @ritikulocyte @manalipatelmd
ascopubs.org/doi/10.1200/OP…
ascopubs.org/doi/10.1200/OP…
ascopubs.org Financial Toxicity of Cancer Care: An Analysis of Financial Burden in Three Distinct Health Care... PURPOSE:The financial toxicity of cancer care is a source of significant distress for patients with cancer. The purpose of this study is to understand factors associated with financial toxicity in... We are conducting a study on the impact of #COVID19 on cancer #providers and their practice. Help us inform ways to improve #cancercare and change policy by taking our provider survey: redcap.stanford.edu/surveys/?s=ARW…
A Call to Action Toward Patient Centricity: GU Cancers Symposium to Feature More Financial and Quality-of-Life Research dailynews.ascopubs.org/do/10.1200/ADN…
dailynews.ascopubs.org A Call to Action Toward Patient Centricity: GU Cancers Symposium to Feature More Financial and... The genitourinary (GU) cancer field is in the midst of an inordinate era of advancement, wherein new discoveries in the areas of detection, novel therapeutic strategies, and personalized medicine...